MGMT and glioblastoma: This action is particularly effective in patients with an increased methylation level in the promoter of the DNA-repairing enzyme O6-methylguanine-DNA methyltransferase (MGMT), thus configuring MGMT as a prognostic and predictive marker in GBM [6,7].